期刊
JOURNAL OF MEDICAL SYSTEMS
卷 45, 期 1, 页码 -出版社
SPRINGER
DOI: 10.1007/s10916-020-01703-6
关键词
ST segment elevation myocardial infarction; Telemedicine; COVID-19; Door-to-balloon time
资金
- Chinese Cardiovascular Association-V.G. fund [2017-CCA-VG-042]
The COVID-19 pandemic has posed challenges for managing cardiovascular patients, and telemedicine offers an effective way to manage patients with acute myocardial infarction during the outbreak.
The coronavirus disease 2019 (COVID-19), which is caused by a novel coronavirus (SARS-COV-2), has compromised health care systems and normal management of patients with cardiovascular diseases [1-3]. Patients with non-communicable diseases, including acute myocardial infarction (AMI) are vulnerable to this stress [4, 5]. Acute ST segment elevation myocardial infarction (STEMI), the most critical type of AMI, is associated with high mortality even with modern medicine [6-8]. Timely reperfusion therapy is critical for STEMI patients because a short ischemia time is associated with better clinical outcomes and lower acute and long -term mortality [9-12]. The COVID-19 pandemic placed the management of STEMI patients in a difficult situation due to the need to balance timely reperfusion therapy and maintaining strict infection control practices [13, 14]. Telemedicine, which is used to deliver health care services using information or communication technology, provides an opportunity to carry out the evaluation, diagnosis, and even monitor the patients after discharge when social distancing is needed [15]. In this article, we reported our preliminary experience with the usefulness of telemedicine in managing STEMI patients during the COVID-19 pandemic. We also provided a review of this topic.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据